DAMORA THERAPEUTICS, INC. Earnings Per Share (Basic)
DAMORA THERAPEUTICS, INC. (DMRA) reported Earnings Per Share (Basic) of -$0.39 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-10
- DAMORA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.39.
- DAMORA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.62.
- DAMORA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$2.36.
- DAMORA THERAPEUTICS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$2.60.
- DAMORA THERAPEUTICS, INC. earnings per share, basic for fiscal 2025 was $3.98.
- DAMORA THERAPEUTICS, INC. earnings per share, basic for fiscal 2024 was -$18.53.
- DAMORA THERAPEUTICS, INC. earnings per share, basic for fiscal 2023 was -$36.08.
- DAMORA THERAPEUTICS, INC. earnings per share, basic for fiscal 2022 was -$2.43.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.39 10-Q · filed 2026-08-10 | -$0.79 10-Q · filed 2026-08-10 | ||||||
| 2026-03-31 | -$0.62 10-Q · filed 2026-05-12 | |||||||
| 2025-12-31 | $3.98 10-K · filed 2026-03-19 | |||||||
| 2025-09-30 | -$2.36 10-Q · filed 2025-11-06 | -$6.88 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | -$2.60 10-Q · filed 2026-08-10 | -$4.51 10-Q · filed 2026-08-10 | ||||||
| 2025-03-31 | -$1.92 10-Q · filed 2026-05-12 | |||||||
| 2024-12-31 | -$18.53 10-K · filed 2026-03-19 | |||||||
| 2024-09-30 | -$3.39 10-Q · filed 2025-11-06 | -$13.30 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | -$4.92 10-Q · filed 2025-08-05 | -$0.20 10-Q · filed 2024-08-12 | -$9.97 10-Q · filed 2025-08-05 | -$0.40 10-Q · filed 2024-08-12 | ||||
| 2024-03-31 | -$5.05 10-Q · filed 2025-05-08 | -$0.20 10-Q · filed 2024-04-29 | ||||||
| 2023-12-31 | -$36.08 10-K · filed 2025-03-19 | -$1.44 10-K · filed 2024-03-08 | ||||||
| 2023-09-30 | -$7.50 10-Q · filed 2024-11-01 | -$0.30 10-Q · filed 2023-11-06 | -$30.19 10-Q · filed 2024-11-01 | -$1.21 10-Q · filed 2023-11-06 | ||||
| 2023-06-30 | -$0.41 10-Q · filed 2024-08-12 | -$0.91 10-Q · filed 2024-08-12 | ||||||
| 2023-03-31 | -$0.51 10-Q · filed 2024-04-29 | |||||||
| 2022-12-31 | -$2.43 10-K · filed 2024-03-08 | |||||||
| 2022-09-30 | -$0.54 10-Q · filed 2023-11-06 | -$1.88 10-Q · filed 2023-11-06 | ||||||
| 2022-06-30 | -$0.67 10-Q · filed 2023-07-31 | -$1.34 10-Q · filed 2023-07-31 | ||||||
| 2022-03-31 | -$0.67 10-Q · filed 2023-04-28 | |||||||
| 2021-12-31 | -$2.05 10-K · filed 2023-03-09 | |||||||
| 2021-09-30 | -$0.50 10-Q · filed 2022-11-08 | -$1.52 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |